Skip to content

OSferion

by Olympus Terumo Biomaterials Corporation

510(k) K080065

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK080065 Date2 May 2008ClearedStatusActive

Official records

From the FDA record

Received by the FDA
10 Jan 2008
FDA decision
2 May 2008 (Substantially Equivalent)
FDA review time
113 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K080065 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MQV
Device class
Class II
Regulation
21 CFR Part 888.3045
Advisory committee
Orthopedic
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

OSferion is a bone graft substitute classified as a bone graft, synthetic under the FDA’s product code MQV. It is designed to provide structural support and promote bone regeneration in orthopedic applications, particularly for spinal and orthopedic surgeries requiring bone void filling or augmentation.

The device is supplied as a sterile, single-use synthetic bone graft substitute and is intended for use in surgical settings. It is regulated under FDA 510(k) clearance (K080065) with a Traditional review pathway, classified under the Orthopedic Advisory Committee. Storage and handling instructions are not specified in the provided data, but compliance with sterile surgical protocols is implied for clinical use.

Devices cleared under K080065

7 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K080065
UDI-DISize and differences
OSferion AR-13370-1
OSFERIONBIOMATERIALS CORP.
AR-13370-1 / AR-13370-104560245656883
Length 12 mm; Length 30 mm; Length 3 mm; Length 7 mm
On the market
OSferion AR-13370-2
OSFERIONBIOMATERIALS CORP.
AR-13370-2 / AR-13370-204560245656890
Length 12 mm; Length 30 mm; Length 3 mm; Length 10 mm
On the market
OSferion AR-13370-3
OSFERIONBIOMATERIALS CORP.
AR-13370-3 / AR-13370-304560245656906
Length 12 mm; Length 35 mm; Length 3 mm; Length 12 mm
On the market
OSferion AR-13370-4
OSFERIONBIOMATERIALS CORP.
AR-13370-4 / AR-13370-404560245656913
Length 12 mm; Length 35 mm; Length 3 mm; Length 15 mm
On the market
OSferion AR-13372-1
OSFERIONBIOMATERIALS CORP.
AR-13372-1 / AR-13372-104560245656951
Angle 75 deg; Length 7 mm; Length 25 mm; Length 8 mm
On the market
OSferion AR-13372-2
OSFERIONBIOMATERIALS CORP.
AR-13372-2 / AR-13372-204560245656968
Angle 75 deg; Length 7 mm; Length 25 mm; Length 9 mm
On the market
OSferion AR-13372-3
OSFERIONBIOMATERIALS CORP.
AR-13372-3 / AR-13372-304560245656975
Angle 75 deg; Length 7 mm; Length 25 mm; Length 10 mm
On the market

Similar devices

Other devices filed under FDA product code MQV (Filler, Bone Void, Calcium Compound).

Other devices from Olympus Terumo Biomaterials Corporation